Boston Scientific
51
23M
33
1.13
14
0.33
16
- Areas of investment
Summary
Boston Scientific appeared to be the Corporate Investor, which was created in 1979. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Marlborough.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Cameron Health, Amphora Medical, Channel Medsystems. We can highlight the next thriving fund investment areas, such as Internet, Medical Device.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Boston Scientific, startups are often financed by ONSET Ventures, Three Arch Partners, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, ONSET Ventures, Aperture Venture Partners. In the next rounds fund is usually obtained by The Vertical Group, New Enterprise Associates, MB Venture Partners.
The current fund was established by John Abele, Pete M. Nicholas. Besides them, we counted 8 critical employees of this fund in our database.
The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2018. The typical startup value when the investment from Boston Scientific is 50-100 millions dollars. Considering the real fund results, this Corporate Investor is 22 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this Boston Scientific works on 3 percentage points more the average amount of lead investments. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 51
- Lead investments
- 14
- Exits
- 16
- Rounds per year
- 1.13
- Follow on index
- 0.33
- Investments by industry
- Health Care (45)
- Medical Device (41)
- Biotechnology (24)
- Medical (15)
- Therapeutics (10) Show 15 more
- Investments by region
-
- United States (45)
- Australia (1)
- Canada (1)
- Israel (2)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 73M
- Group Appearance index
- 0.82
- Avg. company exit year
- 11
- Avg. multiplicator
- 2.92
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Asprodental | 01 Sep 2018 | Seed | 200K | ||
| Channel Medsystems | 23 Aug 2017 | Biotechnology, Health Care, Women's | Late Stage Venture | 14M | United States, California, San Francisco |
| Neuros Medical | 07 Aug 2017 | Health Care, Medical Device, Medical, Life Science, Therapeutics | Early Stage Venture | 20M | United States, Ohio |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.